Navigation Links
bioLytical Partners with Walgreens and Donates HIV Tests for National HIV Testing Day
Date:6/24/2015

bioLytical Laboratories Inc. today announced its support of various HIV testing initiatives and events taking place this week in recognition of National HIV Testing Day on June 27th. The Company has teamed up with Walgreens and Greater Than AIDS to provide free HIV testing and training to local AIDS service organizations and health departments across 150 cities in the United States. This national campaign occurs on and around National HIV Testing Day each year to raise awareness of the HIV/AIDS epidemic and to encourage individuals to get tested.

It is estimated that over 1.1 million people are living with HIV in the United States and one in six don't know they are infected. Individuals on treatment can reduce their risk of spreading the virus by as much as 96%. Early diagnosis and treatment can save lives and is known to reduce the spread of HIV.

bioLytical is proud to be working with Walgreens, one of the largest pharmacy chains in the United States, as well as the Kaiser Family Foundation's group of Community Based Organizations (CBOs), AIDS Service Organizations (ASOs) and private partners who make up the Greater Than AIDS coalition. bioLytical has donated INSTI™ HIV-1/HIV-2 Antibody Kits in support of free HIV testing to be provided at 180 convenient locations across the United States.

“Each partner organization is well suited to contribute to the cause and together we can create greater impact.” said Robert Mackie, President of bioLytical Laboratories. “INSTI is perfectly positioned for this event due to its quick and accurate results. No other test provides results in as little as sixty seconds thus allowing for up to 20 times the testing volume compared to other products on the market.”

Greater Than AIDS is dedicated to increasing awareness of the importance of testing, decreasing stigma, and facilitating conversations and education around testing. Walgreens has committed themselves to the cause like no other pharmacy and serves as a trusted neighborhood resource for testing and treatment, all in a stigma-free setting. bioLytical’s INSTI, its 60 second HIV test, is specifically suited to increase access to testing, increase number of individuals getting tested, all while reducing the anxiety and intimidation around testing.

About bioLytical Laboratories
bioLytical Laboratories is a privately owned Canadian company engaged in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostics using its proprietary INSTI™ technology platform. Today, the company markets and sells its signature INSTI™ HIV test and has a world-wide footprint of regulatory approvals including U.S. FDA approval, Health Canada approval and CE mark from European regulators. Their product provides a highly accurate HIV test result in as little as 60 seconds translating into a compelling value proposition for patients, healthcare professionals and public health organizations. For more information on bioLytical Laboratories, please visit http://www.biolytical.com.

###

Mr. Robert Mackie
info(at)biolytical(dot)com

Read the full story at http://www.prweb.com/releases/2015/06/prweb12808798.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. bioLyticals INSTI HIV Assay Receives FDA Approval for HIV-2
2. bioLytical Laboratories Grants Exclusive Global License for 60 Second Ebola Assay
3. Accelrys Announces Strategic Partnership with USDM
4. NineSigma Announces Winners in $25,000 Sustainable Packaging Challenge in Conjunction With Scientists Without Borders and Partners
5. RoviSys Partners with POMS MES to Expand Life Sciences Capabilities
6. Business Intelligence Consulting Firm NuWare Partners With Yellowfin To Deliver Easy-to-use BI Solutions
7. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
8. Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimers Disease Discoveries
9. ChanTest Announces Their Second User Meeting: Partnerships in Drug Discovery
10. Chemical Publishing Company Partners with Author Cloudware for a Digital eBook Distribution for Water Treatment, Waste Water Treatment, and Cooling Water Treatment Titles
11. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... The award-winning ... to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ... is faced with the challenge of how to continue to feed a growing nation. ...
(Date:10/7/2017)... Arizona (PRWEB) , ... October ... ... 15 years’ experience providing advanced instruments and applications consulting for microscopy and ... in-house expertise in application consulting, Nanoscience Analytical offers a broad range of ...
(Date:10/6/2017)... ... 06, 2017 , ... On Tuesday, October 24th, ABC² (Accelerate ... first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. ... open to the public, but registration is required. , WHAT: ABC² Brain ...
Breaking Biology Technology:
(Date:4/11/2017)... -- NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" ... of independent Directors Mr. Robin D. Richards and ... furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer ... guidance and benefiting from their considerable expertise as we move ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):